GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MDB Capital Holdings LLC MDBH · USD

Financials · US listing · 🇺🇸 United States

Compare

1.50

-3.23%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About MDB Capital Holdings LLC

From its filings with the US Securities and Exchange Commission

SEC filings

MDB Capital Holdings LLC is based in Dallas, Texas and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker MDBH. The SEC classifies its business as finance services. In the fiscal year to 31 December 2025, it reported a net loss of $21.2m. At that date it held total assets of $63.7m and shareholders' equity of $60.7m.

Read the filing on SEC.gov ↗

Company facts

Sector
Financials
Industry
Capital Markets
Listed since
21 Sept 2023
Website
mdb.com ↗
Head office
4209 MEADOWDALE LN, DALLAS, TX, 95229
Incorporated in
DE
Classification
Finance Services
Filer status
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Christopher MarlettChairman of the Board, Chief Executive Officer, since 2021$703,173
  • Mr. George BrandonPresident, Director, since 2021
  • Mr. Jeremy JamesChief Financial Officer
  • Mr. Mohammad HayatHead of Corporate Development and Chief Legal Officer, Director, since 2021$1.1m
  • Mr. Anthony DiGiandomenicoDirector, Head of New Venture Discovery$653,173
  • Mr. Matthew HaydenIndependent Director$322,400
  • Mr. Sean MagennisIndependent Director$186,200
  • Mr. Jeb TerryIndependent Director
  • Mr. Daniel TorpeyIndependent Director$75,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Operates through three wholly owned subsidiaries including MDB Management, Public Ventures, and PatentVest.
  • Has a majority-owned partner company, Invizyne Technologies, Inc., in the technology development segment.
  • IPO occurred on 2023-09-21, indicating recent market entry.

Weaknesses

  • The company is a holding company with no direct operational subsidiaries in the financial data sector.
  • The technology development segment is in the research and development stage, indicating early-stage operations.
  • The source description treats the company as untrusted, suggesting potential reliability issues.

Opportunities

  • Expanding broker dealer & intellectual property service segment through Public Ventures and PatentVest.
  • Leveraging Invizyne's synthetic biology R&D for potential technology development opportunities.
  • Utilizing the IPO date to attract new investors and grow market presence.

Threats

  • The untrusted source description may impact credibility and investor confidence.
  • The research and development stage of Invizyne poses financial and operational risks.
  • Competition in the capital markets industry may affect growth prospects.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.